Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Instagram Outage Disrupts Thousands of U.S. Users 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
 (CAS 157297-01-3) Market Report 2009-2020 - EconoTimes)
Dublin, Sept. 12, 2016 -- Research and Markets has announced the addition of the "Global Market Report On D-Glucosamine-3,6-Di-O-Sulphate (2Na) 2016" report to their offering.
The Global Market Report on D-Glucosamine-3,6-Di-O-Sulphate (2Na) provides comprehensive data on D-Glucosamine-3,6-Di-O-Sulphate (2Na) global and regional markets including Europe, Asia, North America, Latin America, etc. The report captures D-Glucosamine-3,6-Di-O-Sulphate (2Na) market trends and pays close attention to D-Glucosamine-3,6-Di-O-Sulphate (2Na)
The report is broken into three main parts including manufacturing methods & technology development, market landscape & trend analysis, and distribution policy.
In the manufacturing methods & technology development section, the main manufacturing methods of D-Glucosamine-3,6-Di-O-Sulphate (2Na) are introduced.
Key Topics Covered:
Part 1: Introduction of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 1: Brief Introduction of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 2: Product Identification
Chapter 3: Physical Properties
Chapter 4: Quality Specifications
Part 2: Manufacture Methods and Technology Development of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 1: Introduction of Main Manufacture Methods
Chapter 2: Introduction of Patent Manufacture Methods
Chapter 3: New Progress on the Manufacture Technology
Part 3: Application of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 1: Application Review
Chapter 2: End Products(Downstream Products) of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 3: New Applications of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Part 4: Production Situation of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 1: Current Production Situation
Chapter 2: Manufacturers in China
Chapter 3: Manufacturers Outside of China
Chapter 4: Production Trend Analysis
Part 5: Market Situation of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 1: Market Supply Status and Trend Forecast
Chapter 2: Downstream Consumer Market Analysis
Chapter 3: Supply and Demand Analysis and Forecast
Chapter 4: Price Analysis
Chapter 5: Import & Export Situation
Part 6: Distribution Policy of D-Glucosamine-3,6-Di-O-Sulphate (2Na)
Chapter 1: Market Size in Major Use Segments
Chapter 2: Major End Users
Chapter 3: Potential Users
Part 7: References
For more information about this report visit http://www.researchandmarkets.com/research/ww4qw7/global_market
Related Topics: Chemicals, Immune Disorders Drugs
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
